GlassScriptPhysician profile
Whitney J Tackett
NPI 1295174720
$2,039.52
in general payments reported to CMS, 2019-2025
26 companies · $866 in 2025
The $866 reported for 2025 was more than what 81% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $136 · 2023: $338 · 2024: $700 · 2025: $866.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,903.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,903.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $338.67 | 2024-2025 | |
| Novo Nordisk INC | $185.27 | 2023-2025 | Ozempic, Rybelsus, Wegovy |
| Axsome Therapeutics, INC. | $174.27 | 2025 | Auvelity |
| Lilly USA, LLC | $169.93 | 2022-2025 | Mounjaro, Zepbound, Jardiance |
| Corium, LLC | $134.38 | 2023-2025 | Azstarys |
| Baxter Healthcare | $123.77 | 2024 | Perclot |
| Collegium Pharmaceutical, INC. | $112.08 | 2025 | Jornay Pm |
| Glaxosmithkline, LLC. | $108.74 | 2022-2025 | Trelegy Ellipta |
| Pfizer INC. | $106.66 | 2022-2025 | |
| Astrazeneca Pharmaceuticals LP | $88.40 | 2024-2025 | Airsupra |
| Grifols USA, LLC | $73.63 | 2024-2025 | Prolastin-C Liquid |
| Verona Pharma, INC. | $70.51 | 2025 | Ohtuvayre |
| Exact Sciences Corporation | $62.01 | 2023-2024 | Cologuard Collection Kit |
| Boehringer Ingelheim Pharmaceuticals, INC. | $49.26 | 2022-2023 | Spiriva Respimat, Jardiance, Stiolto Respimat |
| Merck Sharp & Dohme LLC | $36.25 | 2023-2024 | Vaxneuvance, Gardasil 9, Rotateq |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biohaven Pharmaceutical Holding Company LTD. | $25.51 | 2022 | |
| Hologic Sales and Service, LLC | $23.91 | 2025 | Thinprep 2000 Processor, Aptima |
| Ultragenyx Pharmaceutical INC. | $22.53 | 2023 | |
| Ironshore Pharmaceuticals INC. | $21.30 | 2023 | Jornay Pm |
| Idorsia Pharmaceuticals US INC | $18.67 | 2023 | Quviviq |
| Phathom Pharmaceuticals, INC. | $17.58 | 2025 | Voquezna |
| Azurity Pharmaceuticals, INC. | $17.34 | 2023 | Edarbi |
| Almatica Pharma LLC | $16.82 | 2024 | Loreev Xr |
| Seqirus USA INC | $16.14 | 2025 | Fluad, Flucelvax |
| Kowa Pharmaceuticals America, INC. | $13.57 | 2024 | Zoryve |
| Endogastric Solutions, INC | $12.32 | 2024 | Esophyx |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Whitney Tackett listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.